Robb Gary Charles: insider trades.
Robb Gary Charles reported 13 non-derivative transactions on 6 SEC ownership filings in Q3 2026: 0 open-market purchases and 1 sale ($1.2M), across 1 company.
- Transactions
- 13
- Purchases (P)
- 0
- Sales (S)
- 1
- Companies
- 1
- Name as filed
- Robb Gary Charles
Companies
| Company | Relationship | Transactions |
|---|---|---|
| Corcept Therapeutics Inc (CORT) | Officer · Chief Business Officer | 13 |
Transactions
| Date | Company | Code | Shares | Price | Owned after | Filing |
|---|---|---|---|---|---|---|
| 2026-09-24 | Corcept Therapeutics Inc | G | 5,000 | $0 | 20,571 | Form 4 |
| 2026-09-24 | Corcept Therapeutics Inc | G | 5,000 | $0 | 20,571 | Form 4 |
| 2026-09-24 | Corcept Therapeutics Inc | G | 17,100 | $0 | 14,056 | Form 4 |
| 2026-09-17 | Corcept Therapeutics Inc | M | 17,493 | $8.27 | 31,156 | Form 4 |
| 2026-09-02 | Corcept Therapeutics Inc | F | 91 | $113.38 | 13,663 | Form 4 |
| 2026-09-01 | Corcept Therapeutics Inc | A | 164 | $113.38 | 13,590 | Form 4 |
| 2026-09-01 | Corcept Therapeutics Inc | A | 164 | $0 | 13,754 | Form 4 |
| 2026-08-17 | Corcept Therapeutics Inc | G | 125 | $0 | 13,426 | Form 4 |
| 2026-08-17 | Corcept Therapeutics Inc | S | 10,000 | $116.26 | 39,716 | Form 4 |
| 2026-08-12 | Corcept Therapeutics Inc | G | 3,000 | $0 | 15,571 | Form 4 |
| 2026-08-12 | Corcept Therapeutics Inc | G | 11,530 | $0 | 13,551 | Form 4 |
| 2026-08-12 | Corcept Therapeutics Inc | G | 3,000 | $0 | 15,571 | Form 4 |
| 2026-05-27 | Corcept Therapeutics Inc | G | 600 | $0 | 25,081 | Form 4 |
Questions
What stock did Robb Gary Charles buy or sell?
Robb Gary Charles reported 13 non-derivative transactions on 6 SEC ownership filings in Q3 2026: 0 open-market purchases and 1 sale ($1.2M), across 1 company.
Is Robb Gary Charles the same person as other filers with this name?
This page covers SEC CIK 1529655 only. The SEC assigns each reporting owner a CIK, and people with the same name have different CIKs.
Source: SEC Insider Transactions Data Sets, Q3 2026. Reported as filed; we do not assess intent, performance or compliance. All filings for this CIK on SEC.gov.
Plain-text version for agents and LLMs: /insiders/robb-gary-charles-1529655.md
Independent. Not affiliated with, endorsed by, or sponsored by the U.S. Securities and Exchange Commission. Data is reproduced from public SEC filings and datasets. Not investment advice.